top of page
Search

Day 99 UZ Leuven


Belgium is conducting a large-scale trial with the plasma of recovered COVID-19 patients. The trial is a collaboration between hospitals in Flanders and is coordinated by UZ (University Hospital) Leuven.


The Red Cross launched a call for recovered corona patients to donate plasma. The plasma is examined for the presence of antibodies that could help sick corona patients. Treating ill patients with the plasma of people that have recovered from the same disease has proven beneficial in the past. The plasma of recovered patients contains antibodies that can help prevent the disease.


In the meantime, UZ Leuven has started a large-scale trial with plasma of recovered COVID-19 patients. If administering plasma proves safe and efficacious, the product could be made available for all patients with corona patients.


Prof. dr. Geert Meyfroidt, national coordinator of the trial says : “Plasma transfusion is a promising therapy for COVID-19 patients and can be made available in a short time-span for a large group of patients all over Europe”.

0 comments

Recent Posts

See All

Astrazeneca, the British – Swedish drug maker, has joined forces with the UK government to support the Oxford University to develop a coronavirus vaccine. The partnership is one the most closely watch

Tresorit, a start up from Switzerland, empowers medical professionals and education institutions with a highly secure way to store and share information. COVID-19 has significantly changed and challen

The Bill and Melinda Gates Foundation is committing to help fight the pandemic. Since its creation in 2000, the foundation has spent over $40 billion on global development and public health programs s

bottom of page